Literature DB >> 34320218

A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma.

Adham M Khalafallah1, Maureen Rakovec1, Chetan Bettegowda1, Christopher M Jackson1, Gary L Gallia1, Jon D Weingart1, Michael Lim2, Yoshua Esquenazi3, Brad E Zacharia4, Ezequiel Goldschmidt5, Mateo Ziu6, Michael E Ivan7, Andrew S Venteicher8, Edjah K Nduom9, Adam N Mamelak10, Ray M Chu10, John S Yu10, Jason P Sheehan11, Brian V Nahed12, Bob S Carter12, Mitchel S Berger13, Raymond Sawaya14, Debraj Mukherjee1,15.   

Abstract

BACKGROUND: Gross total resection (GTR) of contrast-enhancing tumor is associated with increased survival in primary glioblastoma. Recently, there has been increasing interest in performing supratotal resections (SpTRs) for glioblastoma.
OBJECTIVE: To address the published results, which have varied in part due to lack of consensus on the definition and appropriate use of SpTR.
METHODS: A crowdsourcing approach was used to survey 21 neurosurgical oncologists representing 14 health systems nationwide. Participants were presented with 11 definitions of SpTR and asked to rate the appropriateness of each definition. Participants reviewed T1-weighed postcontrast and fluid-attenuated inversion-recovery magnetic resonance imaging for 22 anatomically distinct glioblastomas. Participants were asked to assess the tumor location's eloquence, the perceived equipoise of enrolling patients in a randomized trial comparing gross total to SpTR, and their personal treatment plans.
RESULTS: Most neurosurgeons surveyed (n = 18, 85.7%) agree that GTR plus resection of some noncontrast enhancement is an appropriate definition for SpTR. Overall, moderate inter-rater agreement existed regarding eloquence, equipoise, and personal treatment plans. The 4 neurosurgeons who had performed >10 SpTRs for glioblastomas in the past year were more likely to recommend it as their treatment plan (P < .005). Cases were divided into 3 anatomically distinct groups based upon perceived eloquence. Anterior temporal and right frontal glioblastomas were considered the best randomization candidates.
CONCLUSION: We established a consensus definition for SpTR of glioblastoma and identified anatomically distinct locations deemed most amenable to SpTR. These results may be used to plan prospective trials investigating the potential clinical utility of SpTR for glioblastoma. © Congress of Neurological Surgeons 2021.

Entities:  

Keywords:  Crowdsourcing; Glioblastoma; Neuro-oncology; Supratotal resection

Mesh:

Year:  2021        PMID: 34320218      PMCID: PMC8440068          DOI: 10.1093/neuros/nyab257

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   5.315


  46 in total

1.  Is there a risk of seizures in "preventive" awake surgery for incidental diffuse low-grade gliomas?

Authors:  Guilherme Lucas de Oliveira Lima; Hugues Duffau
Journal:  J Neurosurg       Date:  2015-02-27       Impact factor: 5.115

2.  Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Anna Maria Ascolese; Matteo Simonelli; Armando Santoro; Elena Clerici; Marco Rossi; Marta Scorsetti; Lorenzo Bello
Journal:  J Neurooncol       Date:  2017-07-08       Impact factor: 4.130

3.  Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.

Authors:  David Mampre; Jeffrey Ehresman; Gabriel Pinilla-Monsalve; Maria Alejandra Gamboa Osorio; Alessandro Olivi; Alfredo Quinones-Hinojosa; Kaisorn L Chaichana
Journal:  Br J Neurosurg       Date:  2018-08-03       Impact factor: 1.596

4.  Awake surgery for incidental WHO grade II gliomas involving eloquent areas.

Authors:  Hugues Duffau
Journal:  Acta Neurochir (Wien)       Date:  2011-12-06       Impact factor: 2.216

Review 5.  Association Between Supratotal Glioblastoma Resection and Patient Survival: A Systematic Review and Meta-Analysis.

Authors:  Fatih Incekara; Stephan Koene; Arnaud J P E Vincent; Martin J van den Bent; Marion Smits
Journal:  World Neurosurg       Date:  2019-04-17       Impact factor: 2.104

6.  Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme.

Authors:  P C Burger; P J Dubois; S C Schold; K R Smith; G L Odom; D C Crafts; F Giangaspero
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

Review 7.  Glioblastoma and other malignant gliomas: a clinical review.

Authors:  Antonio Omuro; Lisa M DeAngelis
Journal:  JAMA       Date:  2013-11-06       Impact factor: 56.272

8.  The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.

Authors:  Maryam Rahman; Joseph Abbatematteo; Edward K De Leo; Paul S Kubilis; Sasha Vaziri; Frank Bova; Elias Sayour; Duane Mitchell; Alfredo Quinones-Hinojosa
Journal:  J Neurosurg       Date:  2016-09-30       Impact factor: 5.115

Review 9.  Lessons learned in the development of targeted therapy for malignant gliomas.

Authors:  Antonio M P Omuro; Sandrine Faivre; Eric Raymond
Journal:  Mol Cancer Ther       Date:  2007-07       Impact factor: 6.261

10.  Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.

Authors:  B Jeremic; D Grujicic; V Antunovic; L Djuric; M Stojanovic; Y Shibamoto
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more
  3 in total

1.  A consensus definition of supratotal resection for anatomically distinct primary glioblastoma: an AANS/CNS Section on Tumors survey of neurosurgical oncologists.

Authors:  Maureen Rakovec; Adham M Khalafallah; Oren Wei; David Day; Jason P Sheehan; Jonathan H Sherman; Debraj Mukherjee
Journal:  J Neurooncol       Date:  2022-08-01       Impact factor: 4.506

Review 2.  Preoperative Stereotactic Radiosurgery for Glioblastoma.

Authors:  Eric J Lehrer; Henry Ruiz-Garcia; Anthony D Nehlsen; Kunal K Sindhu; Rachel Sarabia Estrada; Gerben R Borst; Jason P Sheehan; Alfredo Quinones-Hinojosa; Daniel M Trifiletti
Journal:  Biology (Basel)       Date:  2022-01-26

Review 3.  Safe surgery for glioblastoma: Recent advances and modern challenges.

Authors:  Jasper Kees Wim Gerritsen; Marike Lianne Daphne Broekman; Steven De Vleeschouwer; Philippe Schucht; Brian Vala Nahed; Mitchel Stuart Berger; Arnaud Jean Pierre Edouard Vincent
Journal:  Neurooncol Pract       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.